2024-25 Rising Star Grant Award

Enter your keyword

2024-25 Rising Star Grant Award

2024-25 Rising Star Grant Award


The Honorable Tina Brozman Foundation (“Tina’s Wish”) is requesting Proposals for the Tina’s Wish Rising Star Grants for 2024-25.  Tina’s Wish is committed to supporting early career researchers who bring fresh approaches to the study of the early detection or prevention of ovarian cancer.  The goal is to assist and support promising researchers in the ovarian cancer field and to encourage them to take risks and develop innovative projects.


Eligibility and Selection Criteria (applicants must meet ALL the criteria listed)

  1. Applicants must be working in a school of medicine or public health, or a recognized non-profit scientific research facility in the United States.
  2. Applicants must have a committed mentor to support the applicant throughout the grant period.  One’s mentor does not need to be at the same institution as the applicant, provided that the mentor is committed to a meaningful and productive mentorship relationship throughout the grant period.
    1. Please note that if one’s current mentor is not connected to the ovarian cancer research community, please seek out a mentor that is a subject matter expert in the ovarian cancer field. If you need assistance in securing such a mentor, please let Tina’s Wish know (this will not be considered a negative when reviewing your proposal).
  3. The research project for which support is requested should be innovative and not currently funded.
  4. Applicants should hold a PhD, MD, or MD, PhD degree.
    1. PhD applicants must be within three years of completing their degree and be at the postdoctoral level of training or similar (a non-tenured level position) when the grant begins in January, 2024. If one is at the Instructor level, one is eligible to apply for this grant if one’s lab is embedded in a more senior/established lab; if at the Instructor level and as an independent lab, please review the Team Science Grant opportunity).
    2. MD or MD, PhD applicants must be at the instructor or assistant professor level (or a similar faculty position) and within three years of starting their first faculty appointment at the time of the estimated award date (January 2024). Note:  Clinical or research fellows with dedicated research time for the full two years of the Rising Star Grant funding period (January 2024-December 2026) will also be eligible. Fellows should include a letter of institutional commitment of at least 75% research time for the Rising Star Grant funding period with their application.
  5. Note: Prevention studies should be focused on early cancer interception and include chemoprevention strategies.



  1. Two-year grant.
  2. The award’s annual total costs of $75,000 are inclusive of indirect costs, which should not exceed 10%. Total grant $150,000 over 2 years.
  3. The second year of funding is contingent on adequate progress made during the first year of funding.


Selection Process

  1. The Tina’s Wish Scientific Advisory Board and external reviewers will review the proposals and utilize NIH quantitative and qualitative criteria for evaluation.
  2. Criteria used to assess the proposal will include the strength of the scientific proposal, a commitment on the part of the applicant to sustained research on early detection and/or prevention of ovarian cancer, and a strong mentor relationship.



  1. Intent to Apply form deadline: Extended to Monday, March 6th, 12pm ET.
  2. Full Proposal Application deadline: Monday, April 17th, 12pm ET.
  3. Announcement of the 2024-25 Rising Star Grant (RSG) will be made by November 2023.
  4. Written critiques will not be provided to unsuccessful applicants.
  5. Funding will commence on January 1, 2024.


Please click here to access the Intent to Apply form.  Applicants must complete the Intent to Apply form by Wednesday, March 1st, 12pm ET, in order to receive the link to submit a full proposal and the RFP instructions.  The full proposals will be due on or before, Monday, April 17th, 12pm ET.